{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T23:47:56Z","timestamp":1783381676981,"version":"3.54.6"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","diabetesresearchclinicalpractice.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.diabres.2017.10.022","type":"journal-article","created":{"date-parts":[[2017,10,31]],"date-time":"2017-10-31T14:05:50Z","timestamp":1509458750000},"page":"23-29","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"special_numbering":"C","title":["The impact of glycaemic variability on wound healing in the diabetic foot \u2013 A retrospective study of new ulcers presenting to a specialist multidisciplinary foot clinic"],"prefix":"10.1016","volume":"135","author":[{"given":"Ketan K.","family":"Dhatariya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edwin","family":"Li Ping Wah-Pun Sin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joyce Oi Suet","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3619-9579","authenticated-orcid":false,"given":"Francesca Yan Nok","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anson Wei Yue","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Gooday","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Nunney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabres.2017.10.022_b0005","unstructured":"NHS Digital. National Diabetes Inpatient Audit (NaDIA) \u2013 2016; 2017. http:\/\/www.content.digital.nhs.uk\/catalogue\/PUB23539, [accessed 2nd November 2017]."},{"key":"10.1016\/j.diabres.2017.10.022_b0010","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/j.1365-2796.1993.tb01003.x","article-title":"Long-term prognosis for diabetic patients with foot ulcers","volume":"233","author":"Apelqvist","year":"1993","journal-title":"J Intern Med"},{"key":"10.1016\/j.diabres.2017.10.022_b0015","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.2337\/dc06-0306","article-title":"Assessing the outcome of the management of diabetic foot ulcers using ulcer-related and person-related measures","volume":"29","author":"Jeffcoate","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2017.10.022_b0020","doi-asserted-by":"crossref","first-page":"855","DOI":"10.2337\/diacare.21.5.855","article-title":"Validation of a diabetic wound classification system: the contribution of depth, infection, and ischemia to risk of amputation","volume":"21","author":"Armstrong","year":"1998","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2017.10.022_b0025","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.2337\/dc10-2341","article-title":"Time-dependent impact of diabetes on mortality in patients after major lower extremity amputation: Survival in a population-based 5-year cohort in Germany","volume":"34","author":"Icks","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2017.10.022_b0030","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.2337\/dc10-0462","article-title":"Fewer major amputations among individuals with diabetes in Finland in 1997\u20132007","volume":"33","author":"Ikonen","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2017.10.022_b0035","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJM199309303291401","article-title":"The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus","volume":"329","author":"The Diabetes Control and Complications Trial Research Group","year":"1993","journal-title":"N Eng J Med"},{"key":"10.1016\/j.diabres.2017.10.022_b0040","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0140-6736(98)07019-6","article-title":"Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)","volume":"352","author":"UK Prospective Diabetes Study Group","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.diabres.2017.10.022_b0045","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1007\/s00125-015-3797-z","article-title":"Association of the average rate of change in HbA1c with severe adverse events: a longitudinal evaluation of audit data from the Bavarian Disease Management Program for patients with type 2 diabetes mellitus","volume":"59","author":"Bonke","year":"2016","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabres.2017.10.022_b0050","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1210\/jc.2015-3604","article-title":"Association between HbA1c variability and risk of microvascular complications in adolescents with type 1 diabetes","volume":"101","author":"Virk","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.diabres.2017.10.022_b0055","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1002\/dmrr.2404","article-title":"Risk association of HbA1c variability with chronic kidney disease and cardiovascular disease in type 2 diabetes: prospective analysis of the Hong Kong Diabetes Registry","volume":"29","author":"Luk","year":"2013","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.diabres.2017.10.022_b0060","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.2337\/dc15-1188","article-title":"Long-term glycemic variability and risk of adverse outcomes: a systematic review and meta-analysis","volume":"38","author":"Gorst","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2017.10.022_b0065","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.avsg.2007.04.004","article-title":"Glycemic control, lipid-lowering treatment, and prognosis in diabetic patients with peripheral atherosclerotic disease","volume":"21","author":"Feringa","year":"2007","journal-title":"Ann Vasc Surg"},{"key":"10.1016\/j.diabres.2017.10.022_b0070","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1111\/dme.13166","article-title":"Identifying the independent effect of HbA1c variability on adverse health outcomes in patients with Type 2 diabetes","volume":"33","author":"Prentice","year":"2016","journal-title":"Diabetic Med"},{"key":"10.1016\/j.diabres.2017.10.022_b0075","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.diabres.2014.06.007","article-title":"Assessment of the association between glycemic variability and diabetes-related complications in type 1 and type 2 diabetes","volume":"105","author":"Smith-Palmer","year":"2014","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.diabres.2017.10.022_b0080","doi-asserted-by":"crossref","first-page":"84","DOI":"10.2337\/diacare.24.1.84","article-title":"A comparison of two diabetic foot ulcer classification systems: the Wagner and the University of Texas wound classification systems","volume":"24","author":"Oyibo","year":"2001","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2017.10.022_b0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjmed.2013.04.015","article-title":"Risks of diabetic nephropathy with variation in Hemoglobin A1c and fasting plasma glucose","volume":"126","author":"Lin","year":"2013","journal-title":"Am J Med"},{"key":"10.1016\/j.diabres.2017.10.022_b0090","unstructured":"NHS Information Centre. Quality and Outcomes Framework (QOF) \u2013 2015-16; 2016. http:\/\/content.digital.nhs.uk\/article\/2021\/Website-Searchproductid=23378&q=QoF&sort=Relevance&size=10&page=1&area=both#top, [accessed 2nd November 2017]."},{"key":"10.1016\/j.diabres.2017.10.022_b0095","doi-asserted-by":"crossref","first-page":"e000129-","DOI":"10.1136\/bmjdrc-2015-000129","article-title":"The combined effect of visit-to-visit variability in HbA1c and systolic blood pressure on the incidence of cardiovascular events in patients with type 2 diabetes","volume":"3","author":"Takao","year":"2015","journal-title":"BMJ Open Diab Res Care"},{"key":"10.1016\/j.diabres.2017.10.022_b0100","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.2337\/dc08-0864","article-title":"A1C variability and the risk of microvascular complications in type 1 diabetes","volume":"31","author":"Kilpatrick","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2017.10.022_b0105","doi-asserted-by":"crossref","first-page":"e000060-","DOI":"10.1136\/bmjdrc-2014-000060","article-title":"Relationship of HbA1c variability, absolute changes in HbA1c, and all-cause mortality in type 2 diabetes: a Danish population-based prospective observational study","volume":"3","author":"Skriver","year":"2015","journal-title":"BMJ Open Diab Res Care"},{"key":"10.1016\/j.diabres.2017.10.022_b0110","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/414813a","article-title":"Biochemistry and molecular cell biology of diabetic complications","volume":"414","author":"Brownlee","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.diabres.2017.10.022_b0115","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/j.1440-1681.2010.05361.x","article-title":"Glipizide controlled-release tablets, with or without acarbose, improve glycaemic variability in newly diagnosed Type 2 diabetes","volume":"37","author":"Bao","year":"2010","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.diabres.2017.10.022_b0120","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.metabol.2008.10.018","article-title":"Proinflammatory cytokines in response to insulin-induced hypoglycemic stress in healthy subjects","volume":"58","author":"Nematollahi","year":"2009","journal-title":"Metab Clin Exp"},{"key":"10.1016\/j.diabres.2017.10.022_b0125","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1001\/jama.295.14.1681","article-title":"Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes","volume":"295","author":"Monnier","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.diabres.2017.10.022_b0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.diabres.2016.02.006","article-title":"Effect of glucose variability on pathways associated with glucotoxicity in diabetes: evaluation of a novel in vitro experimental approach","volume":"114","author":"Kuricova","year":"2016","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.diabres.2017.10.022_b0135","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.2337\/dc12-2264","article-title":"HbA1c variability as an independent correlate of nephropathy, but not retinopathy, in patients with type 2 diabetes","volume":"36","author":"Penno","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2017.10.022_b0140","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s12882-016-0300-0","article-title":"Excessive visit-to-visit glycemic variability independently deteriorates the progression of endothelial and renal dysfunction in patients with type 2 diabetes mellitus","volume":"17","author":"Wei","year":"2016","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.diabres.2017.10.022_b0145","doi-asserted-by":"crossref","first-page":"e1804-","DOI":"10.1097\/MD.0000000000001804","article-title":"Visit-to-visit glucose variability predicts the development of end-stage renal disease in type 2 diabetes: 10-year follow-up of Taiwan diabetes study","volume":"94","author":"Yang","year":"2015","journal-title":"Medicine"},{"key":"10.1016\/j.diabres.2017.10.022_b0150","doi-asserted-by":"crossref","first-page":"e115509-","DOI":"10.1371\/journal.pone.0115509","article-title":"HbA1C variability and the risk of renal status progression in diabetes mellitus: a meta-analysis","volume":"9","author":"Cheng","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.diabres.2017.10.022_b0155","doi-asserted-by":"crossref","first-page":"e91137-","DOI":"10.1371\/journal.pone.0091137","article-title":"HbA1c variability as an independent risk factor for diabetic retinopathy in type 1 diabetes: a German\/Austrian multicenter analysis on 35,891 patients","volume":"9","author":"Hermann","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.diabres.2017.10.022_b0160","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.2337\/dc14-0199","article-title":"Impact of visit-to-visit glycemic variability on the risks of macrovascular and microvascular events and all-cause mortality in type 2 diabetes: the ADVANCE trial","volume":"37","author":"Hirakawa","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2017.10.022_b0165","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/s00134-010-2129-5","article-title":"Glucose variability measures and their effect on mortality: a systematic review","volume":"37","author":"Eslami","year":"2011","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.diabres.2017.10.022_b0170","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.diabres.2016.02.001","article-title":"Factors determining the risk of diabetes foot amputations \u2013 a retrospective analysis of a tertiary diabetes foot care service","volume":"114","author":"Beaney","year":"2016","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.diabres.2017.10.022_b0175","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.2337\/diacare.26.9.2595","article-title":"Activity patterns of patients with diabetic foot ulceration. Patients with active ulceration may not adhere to a standard pressure off-loading regimen","volume":"26","author":"Armstrong","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2017.10.022_b0180","unstructured":"NHS Digital. National Diabetes Foot Care Audit \u2013 2014\u20132016; 2017. http:\/\/www.content.digital.nhs.uk\/catalogue\/PUB23525, [accessed 2nd November 2017]."},{"key":"10.1016\/j.diabres.2017.10.022_b0185","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1365-2265.2004.02001.x","article-title":"Sources of glucose variability in insulin-treated type 2 diabetes: the Diabetes Outcomes in Veterans Study (DOVES)","volume":"60","author":"Murata","year":"2004","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.diabres.2017.10.022_b0190","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1007\/s00125-008-1226-2","article-title":"Complexity of factors related to outcome of neuropathic and neuroischaemic\/ischaemic diabetic foot ulcers: a cohort study","volume":"52","author":"Gershater","year":"2009","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabres.2017.10.022_b0195","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1046\/j.1464-5491.2001.00422.x","article-title":"The effects of ulcer size and site, patient's age, sex and type and duration of diabetes on the outcome of diabetic foot ulcers","volume":"18","author":"Oyibo","year":"2001","journal-title":"Diabetic Med"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822717312159?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822717312159?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T19:06:28Z","timestamp":1759172788000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822717312159"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":39,"alternative-id":["S0168822717312159"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2017.10.022","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The impact of glycaemic variability on wound healing in the diabetic foot \u2013 A retrospective study of new ulcers presenting to a specialist multidisciplinary foot clinic","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2017.10.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}